Evidence map›Paper›PMID 37226827›Full record

ArticleArchives of pathology & laboratory medicine2024

A Pilot Validation Study Comparing Fluorescence-Imitating Brightfield Imaging, A Slide-Free Imaging Method, With Standard Formalin-Fixed, Paraffin-Embedded Hematoxylin-Eosin-Stained Tissue Section Histology for Primary Surgical Pathology Diagnosis.

Alexander D Borowsky, Richard M Levenson, Allen M Gown, Taryn Morningstar, Thomas A Fleury, Gregory Henderson, Kurt Schaberg, Amelia B Sybenga, Eric F Glassy, Sandra L Taylor and 1 more

Abstract read
In one paragraph

Article in Archives of pathology & laboratory medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Current Landscape of Advanced Imaging Tools for Pathology Diagnostics.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2024
    Review
  8. Review
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexander D BorowskyFrom the Departments of Pathology (Borowsky, Levenson, Morningstar, Schaberg, Fereidouni).
Richard M LevensonFrom the Departments of Pathology (Borowsky, Levenson, Morningstar, Schaberg, Fereidouni).
Allen M GownDepartment of Pathology, University of British Columbia, Vancouver, British Columbia, Canada (Gown).
Taryn MorningstarFrom the Departments of Pathology (Borowsky, Levenson, Morningstar, Schaberg, Fereidouni).
Thomas A FleuryJohns Hopkins Medicine-Sibley Memorial Hospital, Washington, DC (Fleury).
Gregory HendersonPathline LLC, Ramsey, New Jersey (Henderson).
Kurt SchabergFrom the Departments of Pathology (Borowsky, Levenson, Morningstar, Schaberg, Fereidouni).
Amelia B SybengaDepartment of Pathology, University of Vermont Medical Center, Burlington (Sybenga).
Eric F GlassyThe Affiliated Pathologists Medical Group Inc, Rancho Dominguez, California (Glassy).
Sandra L TaylorBiostatistics (Taylor), University of California Davis Health, Sacramento.
Farzad FereidouniFrom the Departments of Pathology (Borowsky, Levenson, Morningstar, Schaberg, Fereidouni).

Funding

3D Microscopy with Ultraviolet Surface Excitation (3D-MUSE)R01EB028635 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI LEVENSON, RICHARD M., WILSON, DAVID LYNN · 2019 to 2023
$2.7M
Breast core-needle diagnostics in LMICs via millifluidics and direct-to-digital imaging: development and validation in GhanaU01CA269191 · NCI · UNIVERSITY OF WASHINGTON · PI RICHARD M. LEVENSON, Eric J Seibel · 2023 to 2026
$2.4M
IMAT-ITCR Collaboration: Combining FIBI and topological data analysis: Synergistic approaches for tumor structural microenvironment explorationR33CA278544 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ICZKOWSKI, KENNETH A · 2023 to 2025
$988k
NCI NIH HHS R33 CA278544NCI NIH HHS U01 CA269191NIBIB NIH HHS R01 EB028635
6 · The paper itself

Abstract

CONTEXT.—: Digital pathology using whole slide images has been recently approved to support primary diagnosis in clinical surgical pathology practices. Here we describe a novel imaging method, fluorescence-imitating brightfield imaging, that can capture the surface of fresh tissue without requiring prior fixation, paraffin embedding, tissue sectioning, or staining. OBJECTIVE.—: To compare the ability of pathologists to evaluate direct-to-digital images with standard pathology preparations. DESIGN.—: One hundred surgical pathology samples were obtained. Samples were first digitally imaged, then processed for standard histologic examination on 4-μm hematoxylin-eosin-stained sections and digitally scanned. The resulting digital images from both digital and standard scan sets were viewed by each of 4 reading pathologists. The data set consisted of 100 reference diagnoses and 800 study pathologist reads. Each study read was compared to the reference diagnosis, and also compared to that reader's diagnosis across both modalities. RESULTS.—: The overall agreement rate, across 800 reads, was 97.9%. This consisted of 400 digital reads at 97.0% versus reference and 400 standard reads versus reference at 98.8%. Minor discordances (defined as alternative diagnoses without clinical treatment or outcome implications) were 6.1% overall, 7.2% for digital, and 5.0% for standard. CONCLUSIONS.—: Pathologists can provide accurate diagnoses from fluorescence-imitating brightfield imaging slide-free images. Concordance and discordance rates are similar to published rates for comparisons of whole slide imaging to standard light microscopy of glass slides for primary diagnosis. It may be possible, therefore, to develop a slide-free, nondestructive approach for primary pathology diagnosis.

Indexed as

Pathology, SurgicalEosine Yellowish-(YS)FormaldehydeHematoxylinHumansMicroscopyParaffin EmbeddingEosine Yellowish-(YS)FormaldehydeHematoxylin

Identifiers

PMID37226827
PMCPMC12054848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.